Back
Aligos Therapeutics Stock Price Chart
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.
Sell
34
ALGS
Aligos Therapeutics
Last Price:
7.29
Seasonality Move:
-18.08%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aligos Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.36 | Buy |
| 20-day SMA: | 8.02 | Sell |
| 50-day SMA: | 11.37 | Sell |
| 200-day SMA: | 16.05 | Sell |
| 8-day EMA: | 7.5 | Sell |
| 20-day EMA: | 8.54 | Sell |
| 50-day EMA: | 10.46 | Sell |
| 200-day EMA: | 15.4 | Sell |
Aligos Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.25 | Sell |
| Relative Strength Index (14 RSI): | 37.43 | Sell |
| Chaikin Money Flow: | 18460 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.68 - 11.86) | Sell |
| Bollinger Bands (100): | (9.44 - 14.44) | Sell |
Aligos Therapeutics Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
- Aligos Therapeutics share price is 7.38 while ALGS 8-day simple moving average is 7.36, which is a Buy signal.
- The stock price of ALGS is 7.38 while Aligos Therapeutics 20-day SMA is 8.02, which makes it a Sell.
- Aligos Therapeutics 50-day simple moving average is 11.37 while ALGS share price is 7.38, making it a Sell technically.
- ALGS stock price is 7.38 and Aligos Therapeutics 200-day simple moving average is 16.05, creating a Sell signal.
ALGS Technical Analysis vs Fundamental Analysis
Sell
34
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a Sell
The current Aligos Therapeutics [ALGS] share price is $7.38. The Score for ALGS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
23.59M
Price in USD:
7.38
Share Volume:
28.72K
Aligos Therapeutics 52-Week Range
52-Week High:
30.00
52-Week Low:
6.76
Sell
34
Aligos Therapeutics (ALGS)
is a Sell
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?
The Aligos Therapeutics stock price is 7.38 USD today. -
Will ALGS stock go up or go down?
Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aligos Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is overvalued.
Is Aligos Therapeutics Stock a Buy?
- Aligos Therapeutics share price is 7.38 while ALGS 8-day exponential moving average is 7.50, which is a Sell signal.
- The stock price of ALGS is 7.38 while Aligos Therapeutics 20-day EMA is 8.54, which makes it a Sell.
- Aligos Therapeutics 50-day exponential moving average is 10.46 while ALGS share price is 7.38, making it a Sell technically.
- ALGS stock price is 7.38 and Aligos Therapeutics 200-day simple moving average is 15.40, creating a Sell signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $37.90 per share, and a decrease next year of $10.24 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
- ALGS Moving Average Covergence Divergence (MACD) indicator is -1.25, suggesting Aligos Therapeutics is a Sell
- Aligos Therapeutics Relative Strength Index (RSI) is 37.43, which suggest Aligos Therapeutics is oversold
- The Bollinger Bands (25) for Aligos Therapeutics is (6.68 - 11.86), which suggest Aligos Therapeutics is a Sell
- The Bollinger Bands (100) for Aligos Therapeutics is (9.44 - 14.44), which suggest Aligos Therapeutics is a Sell
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.